SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (437)5/6/2009 11:12:15 PM
From: mcbio  Read Replies (1) | Respond to of 566
 
I actually now intend to wait until after Phase 2b results are announced before adding to my position. I think that is the safest play here, because the stock is unlikely to soar IMHO after the Phase 2b results are announced. Rather, I think it will get moving once a large partnership is inked, assuming positive Phase 2b results. I think investors want to see large pharma step up to the plate to quell the safety concerns.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News